About Leucovorin Rescue

This Leucovorin Rescue Dose Calculator is an informational tool designed to assist qualified healthcare professionals in determining an appropriate leucovorin dosing schedule following high-dose methotrexate (MTX) administration. Leucovorin is a reduced folate used to counteract the toxic effects of methotrexate on normal cells, a process known as “rescue.” The required dose is critically dependent on the measured plasma MTX concentration and the time elapsed since the start of the infusion.

Calculator Outputs Explained

Upon entering the required patient data, the calculator provides the following key outputs:

• Leucovorin Dose: The calculated dose in milligrams (mg) to be administered at the specified frequency. This is derived by multiplying a dose-per-m² value (based on the risk level) by the patient’s Body Surface Area (BSA).
• Recommended Frequency: The suggested interval for leucovorin administration, typically every 6 hours, until MTX levels fall to a safe threshold.
• Risk Stratification: A risk level (Low, Moderate, or High) based on a standard nomogram that correlates the MTX level with the time post-infusion. This helps contextualize the degree of MTX-induced toxicity risk.

How to Use This Tool

To ensure an accurate calculation, follow these steps:

1. Enter Patient BSA: Input the patient’s Body Surface Area in square meters (m²). If the BSA is unknown, you can check the “Calculate BSA?” box to use the integrated Mosteller formula calculator, which requires the patient’s height and weight.
2. Enter Time Post-Infusion: Input the number of hours that have passed since the start of the high-dose methotrexate infusion. This is a critical parameter, as toxicity thresholds change over time.
3. Enter MTX Level: Input the measured plasma methotrexate concentration. The tool accepts values in micromoles per liter (µmol/L) or moles per liter (mol/L). Ensure the correct unit is selected from the dropdown menu.
4. Calculate: Click the “Calculate Dose” button to generate the recommended leucovorin rescue regimen.

Dosing Overview

Leucovorin rescue protocols are based on nomograms that define toxic MTX concentrations at various time points (e.g., 24, 48, 72 hours) after infusion. If the measured MTX level is above the nomogram line for a specific time point, increased leucovorin dosing is warranted. The goal is to continue rescue with adequate hydration and urinary alkalinization until the MTX level falls below a non-toxic threshold, typically < 0.1 µmol/L. Dosing adjustments should always be guided by institutional protocols and serial MTX level monitoring.

Switching Formulations

Leucovorin is available in both intravenous (IV) and oral (PO) formulations. For high-risk patients or those with critically elevated MTX levels, the IV route is preferred to ensure complete and rapid bioavailability. In low-risk scenarios or as MTX levels decline, a switch to an equivalent oral dosing schedule may be considered, provided the patient has no gastrointestinal issues that could impair absorption. Always consult institutional guidelines for criteria on switching from IV to PO administration.

Missed Dose Protocol

Missing a dose of leucovorin during a rescue regimen can be dangerous and may increase the risk of severe methotrexate toxicity. If a dose is missed, it should be administered as soon as it is remembered. The regular dosing schedule should then be resumed. It is crucial not to double the next dose to make up for the missed one. The clinical team should be notified of any missed doses, as more frequent MTX level monitoring may be required.

Safety Alerts

• Renal Impairment: Methotrexate is primarily cleared by the kidneys. Any renal dysfunction can significantly delay MTX clearance, leading to prolonged exposure to toxic levels. Aggressive hydration and urinary alkalinization (pH > 7.0) are essential to enhance clearance.
• Drug Interactions: Certain medications, such as proton pump inhibitors, NSAIDs, and some antibiotics (e.g., penicillins), can interfere with MTX excretion and increase toxicity. A thorough medication review is required.
• Critically High MTX Levels: For extremely high methotrexate levels (e.g., >50 µmol/L at 48 hours), leucovorin alone may be insufficient. The use of glucarpidase (Voraxaze®), an enzyme that rapidly metabolizes MTX, should be considered in consultation with an oncologist or clinical pharmacist.

Frequently Asked Questions (FAQ)

1. What BSA formula does the sub-calculator use?
The integrated BSA calculator uses the Mosteller formula: BSA (m²) = √([Height(cm) × Weight(kg)] / 3600).

2. Can I use MTX levels reported in units other than µmol/L?
Yes, the tool allows you to select either µmol/L or mol/L. If you select mol/L, the calculator will automatically convert the value to µmol/L for the calculation (e.g., 1e-7 mol/L is converted to 0.1 µmol/L).

3. Why does the recommended dose jump significantly?
The dosing is based on risk thresholds. For example, at 48 hours, an MTX level just under 5 µmol/L is considered moderate risk (100 mg/m² dose), while a level of 5 µmol/L or higher is considered high risk (1000 mg/m² dose). This reflects the exponential increase in toxicity risk above certain nomogram thresholds.

4. What is the basis for the calculator’s dosing logic?
The logic is based on common clinical nomograms used for high-dose methotrexate rescue, which stratify risk and guide leucovorin dosing based on time-dependent MTX concentrations.

5. Is this calculator suitable for pediatric patients?
While the principles of leucovorin rescue apply to all age groups, pediatric dosing protocols can be highly specific. This tool should only be used by professionals familiar with pediatric oncology guidelines, and all results must be verified against institutional protocols.

6. Does the calculator account for renal function?
No, the calculator does not directly take renal function (e.g., creatinine clearance) as an input. It calculates a dose based on the *measured* MTX level, which is itself a direct reflection of MTX clearance. Impaired renal function will lead to higher MTX levels, which will in turn result in a higher recommended leucovorin dose.

7. What should I do if the MTX level is from a time point not at 24, 48, or 72 hours?
The calculator categorizes time into ranges (≤36h, 37-60h, >60h) to apply the correct logic. For a time point like 42 hours, it would use the 48-hour range logic (37-60h).

8. The calculator recommended a 1000 mg/m² dose and mentioned glucarpidase. What does that mean?
A 1000 mg/m² dose indicates a high-risk, toxic MTX level. Glucarpidase is an emergency intervention that breaks down MTX in the blood and may be required when levels are dangerously high and not expected to clear quickly with standard supportive care alone.

9. Can I use this tool for low-dose methotrexate regimens (e.g., for rheumatoid arthritis)?
No. This tool is exclusively for high-dose methotrexate protocols used in oncology. Leucovorin rescue is not typically required for low-dose MTX schedules.

References

1. Howard SC, McCormick J, Pui CH, Buddington RK, Harvey RD. Preventing and Managing Toxicities of High-Dose Methotrexate. Oncologist. 2016;21(12):1471-1482. doi:10.1634/theoncologist.2015-0164. View on NCBI
2. U.S. Food and Drug Administration. Highlights of Prescribing Information: Leucovorin Calcium. Access FDA Label
3. U.S. Food and Drug Administration. Highlights of Prescribing Information: Methotrexate Injection. Access FDA Label
4. Ramsey LB, Balis FM, O’Brien MM, et al. Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate-Induced Acute Kidney Injury and Delayed Methotrexate Clearance. Oncologist. 2018;23(1):57-66. doi:10.1634/theoncologist.2017-0243. View on NCBI
5. National Cancer Institute (NCI). Methotrexate (PDQ®)–Health Professional Version. View on Cancer.gov